The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation.
about
Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirusAn update on respiratory syncytial virus antiviral agents.Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation.Molecular epidemiology of respiratory syncytial virus.Use of a highly sensitive strand-specific quantitative PCR to identify abortive replication in the mouse model of respiratory syncytial virus disease.Immunoprotective activity and safety of a respiratory syncytial virus vaccine: mucosal delivery of fusion glycoprotein with a CpG oligodeoxynucleotide adjuvant.Respiratory syncytial virus infection in the late bone marrow transplant period: report of three cases and review.Prevention and treatment of viral infections in stem cell transplant recipients.Long-Term Shedding of Influenza Virus, Parainfluenza Virus, Respiratory Syncytial Virus and Nosocomial Epidemiology in Patients with Hematological DisordersMolecular characterization of a respiratory syncytial virus outbreak in a hematology unit in Heidelberg, Germany.Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement.Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases.Molecular epidemiology of outbreak of respiratory syncytial virus within bone marrow transplantation unit.Respiratory Syncytial Virus in Hematopoietic Stem Cell Transplantation and Solid-Organ Transplantation.Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit.Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.Palivizumab is highly effective in suppressing respiratory syncytial virus in an immunosuppressed animal model.Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation.Respiratory syncytial virus-related pneumonia after stem cell transplantation successfully treated with palivizumab and steroid therapy.Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins.An outbreak of respiratory syncytial virus infection in a bone marrow transplant unit: effect on engraftment and outcome of pneumonia without specific antiviral treatment.Respiratory syncytial virus infection following hematopoietic stem cell transplantation.Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience.Intravenous ribavirin for respiratory syncytial viral infections in pediatric hematopoietic SCT recipients.
P2860
Q27021622-F2CA9013-C238-4370-8370-529D4EE69D12Q34141078-6E9A4301-1C3D-446B-A19E-33ABBAD55BC2Q34165176-EE32AD05-0EE5-4CAE-8B4C-78814A356459Q34191801-16FA7E80-184A-4852-B3EA-6DDA4835F498Q34198609-44FF1718-C442-48C3-8FB0-D48E303B3D3BQ34226850-04602A67-7D02-4631-89B8-8D83105166BFQ34299730-49B5FEBA-C10D-47E7-9D60-5D554423E6E6Q34722706-9B4C0B8A-E3BD-4409-971E-9549FBD7D128Q35920582-D9DDC6AB-1A96-437F-80A5-22003CAFA6F7Q36506275-B3ACD033-D374-47D5-A6BF-BF5D792AFE73Q36886930-998F2EA3-417F-497D-B3E0-6A1040E03ACCQ38373552-DF85BBB6-B394-40B8-B48E-2A37EC2FAE4BQ39463548-F4FA9D4D-CFCC-4240-A105-659FE25647C5Q41166298-BA4ED451-25DE-4623-B8DE-E329808137ADQ42256954-50CEB363-E0CE-4293-AE11-B5C777B041F5Q42262215-D4A92FED-3D62-4942-A7BD-339A412C1C2BQ43407951-2854917F-B942-4A9E-84BE-5BDB5C165FC5Q43848095-CC94759D-612B-4E2C-9A9E-8B4529EF6B6DQ43890868-6D984D73-7038-4EBB-B587-565A0D8402E6Q44828154-94637008-2883-4106-B2DA-D2E132CF118EQ45070426-C5520395-26BB-46E9-9D0D-A235F58783BAQ45722741-737320CA-B0F5-4003-98AC-5BD6188597FDQ45733327-23FB02C2-E0FE-4D16-8780-A89AD0EB1798Q47819070-A9DCA788-2F1F-4867-BCE6-E7006DDB2662Q50550990-184CB98F-8CAD-4DF8-AA40-3F0FB98E0A27
P2860
The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
The outcome of 26 patients wit ...... eic stem cell transplantation.
@en
type
label
The outcome of 26 patients wit ...... eic stem cell transplantation.
@en
prefLabel
The outcome of 26 patients wit ...... eic stem cell transplantation.
@en
P2093
P356
P1476
The outcome of 26 patients wit ...... eic stem cell transplantation.
@en
P2093
Cornish JM
Kingman HM
McCarthy AJ
P2888
P304
P356
10.1038/SJ.BMT.1702078
P407
P577
1999-12-01T00:00:00Z
P5875
P6179
1051935693